N,N'-((4,4'-(Naphthalene-2,7-diyl)bis(1H-1,2,3-triazole-4,1-diyl))bis(3,1-phenylene))bis(2-(pyrrolidin-1-yl)acetamide)

ID: ALA2069620

PubChem CID: 70674277

Max Phase: Preclinical

Molecular Formula: C38H38N10O2

Molecular Weight: 666.79

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN1CCCC1)Nc1cccc(-n2cc(-c3ccc4ccc(-c5cn(-c6cccc(NC(=O)CN7CCCC7)c6)nn5)cc4c3)nn2)c1

Standard InChI:  InChI=1S/C38H38N10O2/c49-37(25-45-15-1-2-16-45)39-31-7-5-9-33(21-31)47-23-35(41-43-47)28-13-11-27-12-14-29(20-30(27)19-28)36-24-48(44-42-36)34-10-6-8-32(22-34)40-38(50)26-46-17-3-4-18-46/h5-14,19-24H,1-4,15-18,25-26H2,(H,39,49)(H,40,50)

Standard InChI Key:  AKJFTBQRELUULK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 50 57  0  0  0  0  0  0  0  0999 V2000
   -0.6681   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6693   -4.1523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0456   -4.5652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0438   -2.9122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7591   -3.3213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7599   -4.1482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4752   -4.5591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1902   -4.1444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1855   -3.3144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4696   -2.9072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3836   -4.5615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1371   -4.2254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6896   -4.8381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2776   -5.5529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4706   -5.3819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9059   -4.5517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9954   -5.3718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8030   -5.5402    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2128   -4.8241    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6583   -4.2133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5097   -4.7524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8439   -3.9969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6635   -3.9097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1498   -4.5772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8107   -5.3340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9921   -5.4175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0313   -4.7342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5184   -5.4014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3379   -5.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6712   -4.5567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1790   -3.8893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3613   -3.9817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2938   -6.0027    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9562   -6.7555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4393   -7.4243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1355   -6.8395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1017   -8.1770    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8251   -5.9780    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4922   -6.7329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9794   -7.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6465   -8.1535    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6720   -6.8220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5112   -8.8952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9575   -9.5068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2047   -9.1692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2933   -8.3490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8417   -8.3314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7583   -9.1522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5132   -9.4851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0630   -8.8700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 23 24  2  0
  2  3  1  0
 24 25  1  0
  5  6  1  0
 25 26  2  0
 26 21  1  0
 13 21  1  0
  3  6  2  0
  6  7  1  0
 27 28  2  0
 12 13  1  0
 28 29  1  0
 13 14  1  0
 29 30  2  0
 14 15  2  0
 30 31  1  0
 15 11  1  0
 31 32  2  0
 32 27  1  0
 19 27  1  0
  2 11  1  0
 25 33  1  0
 16 17  1  0
 33 34  1  0
  1  2  2  0
 34 35  1  0
  7  8  2  0
 34 36  2  0
  5  4  2  0
 35 37  1  0
  8  9  1  0
 29 38  1  0
  4  1  1  0
 38 39  1  0
 17 18  2  0
 39 40  1  0
 18 19  1  0
 40 41  1  0
 19 20  1  0
 39 42  2  0
 37 43  1  0
 20 16  2  0
  8 16  1  0
  9 10  2  0
 10  5  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 46 37  1  0
 41 47  1  0
 21 22  2  0
 11 12  2  0
 22 23  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 41  1  0
M  END

Associated Targets(Human)

HOS (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MG-63 (795 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOS-TE85 (154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SAOS-2 (672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OST (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HPAC (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WI-38 (2654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 666.79Molecular Weight (Monoisotopic): 666.3179AlogP: 5.40#Rotatable Bonds: 10
Polar Surface Area: 126.10Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.98CX Basic pKa: 7.86CX LogP: 5.51CX LogD: 4.73
Aromatic Rings: 6Heavy Atoms: 50QED Weighted: 0.20Np Likeness Score: -1.21

References

1. Lombardo CM, Welsh SJ, Strauss SJ, Dale AG, Todd AK, Nanjunda R, Wilson WD, Neidle S..  (2012)  A novel series of G-quadruplex ligands with selectivity for HIF-expressing osteosarcoma and renal cancer cell lines.,  22  (18): [PMID:22889802] [10.1016/j.bmcl.2012.07.009]

Source